Latest Data & Signals Issued

Below are some of the latest signals issued for Amicus Therapeutics

General

Signal Type Signal Value Data
Score 0.000 156 days ( -71.68 %
Last Price $14.49 0 %
Performance History
7 Days
$14.49 $14.49
0%
30 Days
$14.49 $14.49
0%
12 Mos
$6.26 $14.49
131.47%

8/18

Active Buy Signals

Specific Signals

Short Term
Net score: 39.19
Signal Type Signal Value Importance Data
High / Low N/A Very Low $14.49 - $14.49
Trend - 3 mos 1.03 % High Width: 0.550 %
Pred. range - 3 mos $14.62 - $14.70 Low 0.93 % - 1.48 %
Volume Direction Sell High Volume: 49 · Direction: 0
Pivot Short Sell Very Low Jun 02, 2026 - 2 days
RSI Short Pivot Signal Sell Very Low May 05, 2026 - 21 days
Short MA 3 mos Buy Low Apr 17, 2026 - 33 days
Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days
Short/Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 68.5
Signal Type Signal Value Importance Data
Trend - 12 mos 160.98 % Very High Width: 19.50 %
Pred. range - 12 mos $39.87 - $47.65 High 175.17 % - 228.82 %
Short MA 12 mos Buy Very High Feb 05, 2026 - 82 days
Long MA 12 mos Buy Very High Aug 01, 2025 - 211 days
Short/Long MA 12 mos Buy Very High Aug 14, 2025 - 202 days
Pivot Long Sell Low Jun 02, 2026 - 2 days
RSI Long Pivot Signal Sell Low May 14, 2026 - 14 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Sell High No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Click to get the best stock tips daily for free!
ABOUT AMICUS THERAPEUTICS
Amicus Therapeutics
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant based on in vitro assay data. It also develops AT-GAA, a novel treatment paradigm for Pompe disease; enzym...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE